RxDoctor Payments Data

Timothy Lyon, MD

Urology · Jacksonville, FLNPI 1760777957

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,665 of the $20,313 with a category attached, or 62.3%. 19 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 28.1% of the total. 2025 is the largest year on record at $10,340, more than ten times the $310 reported in 2019.

$20,313in general payments, 2019–2025

Across 54 payments — averaging $376.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$6K
  • Urogen Pharma, Inc.$4K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Janssen Global Services, LLC$3K
  • Photocure Inc$1K
  • Cook Medical LLC$735
  • plus $3K from 13 others
$893,359in research payments, 2019–2025

Across 39 payments — averaging $22,907 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$703K
  • Janssen Research & Development, LLC$161K
  • Ferring Pharmaceuticals AS$30K

What the payments were for

  • Consulting fees$12,66562%
  • Speaking & faculty fees$3,20016%
  • Travel & lodging$2111%
  • Food & beverage$4,18921%
  • Education$490%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,313 in reported general payments places this provider in the 85th percentile of 935 urology providers in Florida.

See all urology providers in Florida

Medicare billing

Part B allowed, 2024
$819,623
Medicare patients
559
Services billed
18,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl18$381
Oxybutynin Chloride ErOxybutynin Chloride25$300

Paid to pharmacies, not to this prescriber.

Other urology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →